February 27, 2014: The Food and Drug Administration announces proposed changes to nutrition labels, the first overhaul in more than 20 years. The new label, right, would emphasize calories and added sugars.
FDA
Recent FDA actions —
February 4, 2014: The FDA launches an anti-smoking campaign aimed at youths ages 12 to 17 across multiple media platforms.
FDA
Recent FDA actions —
January 15, 2014: The FDA asks health care workers to stop prescribing combination drugs with acetaminophen doses over 325 milligrams. Overdoses can lead to liver failure or death.
Joe Amon/The Denver Post/Getty Images
Recent FDA actions —
December 16, 2013: Under a proposed FDA rule, manufacturers of antibacterial hand soap and body wash will be required to prove their products are more effective than plain soap and water in preventing illness and the spread of infection. Hand sanitizers and wipes are not covered by the proposed rule.
Photo Illustration/Thinkstock
Recent FDA actions —
December 11, 2013: The FDA announces it wants to phase out the use of certain antibiotics in food-producing animals.
Joern Pollex/Getty Images
Recent FDA actions —
November 25, 2013: The FDA loosens restrictions on the diabetes drug Avandia, which had been in place since 2010 because of worries it caused serious heart problems. Additional research found no extra cardiovascular risk.
Jonathan Schaer/cnn/file
Recent FDA actions —
November 8, 2013: The FDA takes a first step toward eliminating artificial trans fats in the food supply.
Jeff J Mitchell/Getty Images
Recent FDA actions —
October 25, 2013: For the first time, the FDA proposes rules to protect animal foods from bacteria and contaminants. Up until then, there were no regulations over production of most animal food.
Joe Raedle/Getty Images
Recent FDA actions —
August 2, 2013: The FDA sets a final standard to clearly define what the term "gluten-free" means on food labels.
Justin Sullivan/Getty Images/file
Recent FDA actions —
June 27, 2013: The FDA shuts down 1,677 online pharmacies for selling counterfeit or substandard medicine, or for selling drugs without appropriate safeguards.
